NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · USD

NEXGEL, Inc. (NXGLW) Stock Analysis

NEXGEL, Inc. (NXGLW) is a stock listed on NASDAQ and quoted in US Dollar.

NXGLW

$0.01

+$0.00 (+1.63%)

Sep 4, 2026 · Market close

This is a derivative instrument — a warrant on NEXGEL, Inc. (NXGL) common stock.

Issuer fundamentals are shown on the issuer page, not here.

View NXGL →

Price History

Hover for the daily close. The dotted line marks the period open.

NXGLW Key Statistics

As of Sep 4, 2026
Trading
Open
$0.31
Previous Close
$0.01
Day's Range
0.01–0.02
52-Week Range
0.01–0.02
Volume
8.77K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.75

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

About NEXGEL, Inc.

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Visit website →